2019 visionary finalist: Ondine Biomedical Inc.

Our innovation is: “life-saving, breakthrough, game-changing”

— Carolyn Cross, Chairman and CEO, Ondine Biomedical Inc.

Organization: 
Ondine Biomedical Inc.

Finalist category: 
The visionary

Industry: 
Biomedical

What problem is the innovation trying to solve?

"Ondine’s innovation directly targets the global threat of drug resistance. Identified by the World Health Organization as one of the top five human health crises, drug-resistant infections are forecast to cause a staggering 10 million deaths and have a US$100-trillion economic impact annually by 2050: more than cancer, diabetes and cholera combined!"

— Carolyn Cross, Chairman and CEO, Ondine Biomedical Inc.

The innovation:

"Ondine’s Photodisinfection is a patented, light-activated antimicrobial system that kills drug-resistant germs of all kinds in minutes without the use of antibiotics. Already in use at Vancouver General Hospital and UBC Hospital, it has helped prevent hundreds of post-surgical infections and saved millions of dollars annually in avoided infection costs."

— Carolyn Cross, Chairman and CEO, Ondine Biomedical Inc.

Explore other V2R Awards winners and finalists stories

Contact us

Vision to Reality Awards team

, PwC Canada

Follow PwC Canada